PTC THERAPEUTICS, INC. (PTCT)
PTC THERAPEUTICS, INC. (PTCT)
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 833,986 | 984,648 | 672,617 | 1,017,386 |
| Marketable securities | 1,058,477 | 960,723 | 1,015,200 | 971,764 |
| Trade and royalty receivables, net | 219,919 | 181,621 | 203,074 | 196,133 |
| Inventory, net | 75,567 | 79,647 | 52,688 | 34,061 |
| Prepaid expenses and other current assets | 66,054 | 67,309 | 64,224 | 53,531 |
| Total current assets | 2,254,003 | 2,273,948 | 2,007,803 | 2,272,875 |
| Fixed assets, net | 52,739 | 55,371 | 56,970 | 57,189 |
| Intangible assets, net | 380,684 | 388,753 | 396,466 | 143,806 |
| Goodwill | 82,341 | 82,341 | 82,341 | 82,341 |
| Operating lease rou assets | 76,692 | 80,053 | 80,682 | 56,162 |
| Deposits and other assets | 22,645 | 18,301 | 19,438 | 21,782 |
| Total assets | 2,869,104 | 2,898,767 | 2,643,700 | 2,634,155 |
| Accounts payable and accrued expenses | 313,050 | 381,272 | 303,141 | 338,945 |
| Current portion of long-term debt | 286,937 | 286,631 | 286,319 | NaN |
| Deferred revenue | 498 | 2,040 | 1,691 | 9,760 |
| Operating lease liabilities- current | 12,078 | 12,484 | 11,810 | 11,725 |
| Finance lease liabilities- current | 6,000 | 3,000 | 2,676 | 5,358 |
| Liability for sale of future royalties- current | 305,041 | 283,000 | 260,608 | 262,021 |
| Total current liabilities | 923,604 | 968,427 | 866,245 | 627,809 |
| Operating lease liabilities- noncurrent | 90,072 | 93,583 | 95,488 | 71,237 |
| Finance lease liabilities- noncurrent | NaN | 3,000 | 13,833 | 13,833 |
| Long-term debt | NaN | NaN | NaN | 286,013 |
| Liability for sale of future royalties- noncurrent | 2,022,189 | 2,025,366 | 1,821,313 | 1,833,985 |
| Other long-term liabilities | 13,704 | 13,704 | 2,579 | 7,824 |
| Total liabilities | 3,049,569 | 3,104,080 | 2,799,458 | 2,840,701 |
| Common stock, 0.001 par value. authorized 250,000,000 shares issued and outstanding 82,882,024 shares at march 31, 2026. authorized 250,000,000 shares issued and outstanding 81,474,366 shares at december 31, 2025 | 81 | 80 | 79 | 78 |
| Additional paid-in capital | 2,778,026 | 2,748,335 | 2,667,497 | 2,631,180 |
| Accumulated other comprehensive income | 8,466 | 10,501 | 5,930 | 7,356 |
| Accumulated deficit | -2,967,038 | -2,964,229 | -2,829,264 | -2,845,160 |
| Total stockholders' deficit | -180,465 | -205,313 | -155,758 | -206,546 |
| Total liabilities and stockholders' deficit | 2,869,104 | 2,898,767 | 2,643,700 | 2,634,155 |